Expression of SGLT1 in Human Hearts and Impairment of Cardiac Glucose Uptake by Phlorizin during Ischemia-Reperfusion Injury in Mice

Tropomodulin3 is a novel Akt2 effector regulating insulin-stimulated GLUT4 exocytosis through cortical actin remodeling

(2015) Chun-Yan Lim et al.   Nature Communications

Phlorizin Prevents Electrically-Induced Ventricular Tachyarrhythmia during Ischemia in Langendorff-Perfused Guinea-Pig Hearts

(2014) Masamichi Hirose et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice

(2014) Bowen Lin et al.   Cardiovascular Diabetology

Arachidonate 12/15-Lipoxygenase–Induced Inflammation and Oxidative Stress Are Involved in the Development of Diabetic Cardiomyopathy

(2014) Hirofumi Suzuki et al.   DIABETES

Preconditioning actions of aldosterone through p38 signaling modulation in isolated rat hearts

(2014) Takuya Yoshino et al.   JOURNAL OF ENDOCRINOLOGY

Transgenic Knockdown of Cardiac Sodium/Glucose Cotransporter 1 (SGLT1) Attenuates PRKAG2 Cardiomyopathy, Whereas Transgenic Overexpression of Cardiac SGLT1 Causes Pathologic Hypertrophy and Dysfunction in Mice

(2014) Mohun Ramratnam et al.   Journal of the American Heart Association

Transient decrease in serum potassium level during ischemic attack of acute coronary syndrome: Paradoxical contribution of plasma glucose level and glycohemoglobin

(2013) Hiroshi Sekiyama et al.   Cardiovascular Diabetology

Novel Hypothesis to Explain Why SGLT2 Inhibitors Inhibit Only 30-50% of Filtered Glucose Load in Humans

(2013) M. A. Abdul-Ghani et al.   DIABETES

MAP17 and SGLT1 Protein Expression Levels as Prognostic Markers for Cervical Tumor Patient Survival

(2013) Marco Perez et al.   PLoS One

An Immunohistochemical Analysis of Tissue Thrombin Expression in the Human Atria

(2013) Keiichi Ito et al.   PLoS One

SGLT inhibitors in management of diabetes

(2013) Abd A Tahrani et al.   Lancet Diabetes & Endocrinology

Regional distribution of SGLT activity in rat brain in vivo

(2012) Amy S. Yu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Development of a cell-based nonradioactive glucose uptake assay system for SGLT1 and SGLT2

(2012) Abhinav Kanwal et al.   ANALYTICAL BIOCHEMISTRY

The role of Na+/H+ exchanger in Ca2+ overload and ischemic myocardial damage in hearts from type 2 diabetic db/db mice

(2012) Ryuko Anzawa et al.   Cardiovascular Diabetology

Biphasic Action of Aldosterone on Akt Signaling in Cardiomyocytes

(2012) T. Nagoshi et al.   HORMONE AND METABOLIC RESEARCH

An enzymatic photometric assay for 2-deoxyglucose uptake in insulin-responsive tissues and 3T3-L1 adipocytes

(2011) Kumiko Saito et al.   ANALYTICAL BIOCHEMISTRY

NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1

(2011) Magali Balteau et al.   CARDIOVASCULAR RESEARCH

Optimization of Cardiac Metabolism in Heart Failure

(2011) Tomohisa Nagoshi et al.   CURRENT PHARMACEUTICAL DESIGN

Na+-D-glucose Cotransporter SGLT1 is Pivotal for Intestinal Glucose Absorption and Glucose-Dependent Incretin Secretion

(2011) V. Gorboulev et al.   DIABETES

Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injury

(2011) Jun Yoshioka et al.   JOURNAL OF CLINICAL INVESTIGATION

Biology of Human Sodium Glucose Transporters

(2011) Ernest M. Wright et al.   PHYSIOLOGICAL REVIEWS

Functional effects of glucose transporters in human ventricular myocardium

(2010) Dirk von Lewinski et al.   EUROPEAN JOURNAL OF HEART FAILURE

SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy

(2010) Sanjay K. Banerjee et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Glucose-transporter–mediated positive inotropic effects in human myocardium of diabetic and nondiabetic patients

(2010) Dirk von Lewinski et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

SGLT2 inhibition — a novel strategy for diabetes treatment

(2010) Edward C. Chao et al.   NATURE REVIEWS DRUG DISCOVERY

SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states

(2009) S. K. Banerjee et al.   CARDIOVASCULAR RESEARCH

Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction

(2009) Stuart A. Cook et al.   EUROPEAN HEART JOURNAL

Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats

(2008) S. Han et al.   DIABETES